Poolbeg to Participate in Key Conferences in March and April 2025
Poolbeg to present at Master Investor Show, BioTrinity & Participate in a Panel Discussion at LSX World Congress
27 March 2025 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that CEO, Jeremy Skillington, will be participating in the following leading industry conferences in March and April 2025.
